Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab in Rituximab-Refractory Follicular Lymphoma
NCT00394836Phase 2Completed
- Sponsor
- GSK
- Start
- May 2007
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in follicular lymphoma (FL), sponsored by GSK. Started May 2007; status: completed.
02
Drugs
ofatumumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00394836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394836.